Patent · US Expired

4-methylene-2-oxo-8-azaspiro[4,5]decane derivatives, pharmaceutical compositions containing them and process for preparing same

US5132303A · kind A · utility

8Cited by
1References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 10, 1990
Grant dateJul 21, 1992
Priority date
Expiry dateAug 10, 2010

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P25/28
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention relates to novel, therapeutically active 4-methylene-2-oxo-8-azaspiro[4,5]decane derivatives of the compound, ##STR1## wherein X means oxygen or an >NR group, wherein PA1 R stands for hydrogen, C.sub.1-12 alkyl, C.sub.3-6 cycloalkyl, carbocyclic C.sub.6-10 aryl or carbocyclic C.sub.6-10 arylC.sub.1-4 alkyl group, the latter two being optionally substituted on their aromatic moiety by one or more, same or different halogen(s) or one or more C.sub.1-4 alkyl group(s) or by one or more C.sub.1-4 alkoxy group(s); PA0 R.sup.3 and R.sup.4, which are the same or different, represent hydrogen, one or more halogen(s), C.sub.1-4 alkyl, C.sub.1-4 alkoxy, trihalomethyl group or hydroxyl group optionally esterified by a C.sub.1-4 alkanoic acid; and PA0 is 1 or 2, their isomers, solvates, hydrates, acid addition and quaternary ammonium salts.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.